Ambarani, Anesan .
HRN: 26-30-93 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2025
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
08/05/2025
08/07/2025
ORAL
5ml
BID
AGE; For Deworming
Checking Initial Appropriateness
08/06/2025
CEFUROXIME 750MG (VIAL)
08/06/2025
08/13/2025
IV
200mg
Q8hours
PCAP-B
Checking Initial Appropriateness